Zhende Medical Co Ltd

SHG:603301 China Medical Instruments & Supplies
Market Cap
$3.35 Billion
CN¥24.56 Billion CNY
Market Cap Rank
#6227 Global
#924 in China
Share Price
CN¥92.38
Change (1 day)
-0.46%
52-Week Range
CN¥19.14 - CN¥99.94
All Time High
CN¥99.94
Categories
Companies in China Medical Instruments & Supplies
About

Zhende Medical Co., Ltd. engages in the research and development, production, and sale of medical care and protective equipment in China and internationally. The company offers gauze swab, lap sponge, and fluff gauze swab; non-woven swab; PBT bandage, elastic bandage, crepe bandage, crochet bandage, selvedge bandage, under-cast padding, and fluff gauze roll; dressing set; first aid kit; cotton pa… Read more

Zhende Medical Co Ltd (603301) - Net Assets

Latest net assets as of September 2025: CN¥5.99 Billion CNY

Based on the latest financial reports, Zhende Medical Co Ltd (603301) has net assets worth CN¥5.99 Billion CNY as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥8.40 Billion) and total liabilities (CN¥2.42 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥5.99 Billion
% of Total Assets 71.22%
Annual Growth Rate 49.49%
5-Year Change 32.0%
10-Year Change 2146.71%
Growth Volatility 69.7

Zhende Medical Co Ltd - Net Assets Trend (2014–2024)

This chart illustrates how Zhende Medical Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Zhende Medical Co Ltd (2014–2024)

The table below shows the annual net assets of Zhende Medical Co Ltd from 2014 to 2024.

Year Net Assets Change
2024-12-31 CN¥5.90 Billion +5.21%
2023-12-31 CN¥5.60 Billion -2.65%
2022-12-31 CN¥5.76 Billion +29.67%
2021-12-31 CN¥4.44 Billion -0.61%
2020-12-31 CN¥4.47 Billion +219.14%
2019-12-31 CN¥1.40 Billion +24.45%
2018-12-31 CN¥1.12 Billion +100.76%
2017-12-31 CN¥560.19 Million +27.85%
2016-12-31 CN¥438.18 Million +66.96%
2015-12-31 CN¥262.45 Million +148.13%
2014-12-31 CN¥105.77 Million --

Equity Component Analysis

This analysis shows how different components contribute to Zhende Medical Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 339202133626.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings CN¥3.38 Billion 59.86%
Common Stock CN¥266.45 Million 4.72%
Other Comprehensive Income CN¥233.51 Million 4.14%
Other Components CN¥1.77 Billion 31.28%
Total Equity CN¥5.64 Billion 100.00%

Zhende Medical Co Ltd Competitors by Market Cap

The table below lists competitors of Zhende Medical Co Ltd ranked by their market capitalization.

Company Market Cap
Tokuyama Corporation
F:TBT
 		$1.33 Billion
Proto Labs Inc
NYSE:PRLB
 		$1.33 Billion
Lianhe Chemical Technology Co Ltd
SHE:002250
 		$1.33 Billion
Hengbao Co Ltd
SHE:002104
 		$1.33 Billion
Everdisplay Optronics Shanghai Co Ltd
SHG:688538
 		$1.33 Billion
Bank of East Asia Limited
PINK:BKEAY
 		$1.33 Billion
Aroundtown S.A.
LSE:0RUH
 		$1.33 Billion
Wolverine World Wide Inc
NYSE:WWW
 		$1.33 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Zhende Medical Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 5,365,596,147 to 5,643,251,376, a change of 277,655,229 (5.2%).
  • Net income of 385,170,729 contributed positively to equity growth.
  • Dividend payments of 159,395,258 reduced retained earnings.
  • Other comprehensive income increased equity by 233,510,910.
  • Other factors decreased equity by 181,631,152.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income CN¥385.17 Million +6.83%
Dividends Paid CN¥159.40 Million -2.82%
Other Comprehensive Income CN¥233.51 Million +4.14%
Other Changes CN¥-181.63 Million -3.22%
Total Change CN¥- 5.17%

Book Value vs Market Value Analysis

This analysis compares Zhende Medical Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 4.35x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 136.33x to 4.35x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2014-12-31 CN¥0.68 CN¥92.38 x
2015-12-31 CN¥1.77 CN¥92.38 x
2016-12-31 CN¥2.99 CN¥92.38 x
2017-12-31 CN¥3.80 CN¥92.38 x
2018-12-31 CN¥6.23 CN¥92.38 x
2019-12-31 CN¥6.93 CN¥92.38 x
2020-12-31 CN¥20.51 CN¥92.38 x
2021-12-31 CN¥17.95 CN¥92.38 x
2022-12-31 CN¥23.35 CN¥92.38 x
2023-12-31 CN¥20.01 CN¥92.38 x
2024-12-31 CN¥21.24 CN¥92.38 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Zhende Medical Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 6.83%
  • The company has moderate efficiency in generating returns from equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 9.03%
  • • Asset Turnover: 0.56x
  • • Equity Multiplier: 1.34x
  • Recent ROE (6.83%) is below the historical average (19.52%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2014 21.97% 2.21% 0.89x 11.20x CN¥11.86 Million
2015 30.57% 7.74% 0.80x 4.93x CN¥53.19 Million
2016 18.94% 8.00% 0.92x 2.58x CN¥39.10 Million
2017 21.77% 9.32% 1.01x 2.31x CN¥65.85 Million
2018 11.59% 9.11% 0.77x 1.65x CN¥17.83 Million
2019 11.55% 8.40% 0.70x 1.96x CN¥21.01 Million
2020 60.95% 24.52% 1.62x 1.53x CN¥2.13 Billion
2021 14.65% 11.70% 0.79x 1.58x CN¥189.19 Million
2022 12.27% 11.08% 0.78x 1.43x CN¥125.71 Million
2023 3.70% 4.81% 0.57x 1.35x CN¥-338.16 Million
2024 6.83% 9.03% 0.56x 1.34x CN¥-179.15 Million

Industry Comparison

This section compares Zhende Medical Co Ltd's net assets metrics with peer companies in the Medical Instruments & Supplies industry.

Industry Context

  • Industry: Medical Instruments & Supplies
  • Average net assets among peers: $2,246,530,775
  • Average return on equity (ROE) among peers: 12.28%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Zhende Medical Co Ltd (603301) CN¥5.99 Billion 21.97% 0.40x $1.33 Billion
Beijing Centergate Technologies Holding Co Ltd (000931) $2.03 Billion -9.26% 2.64x $356.80 Million
Blue Sail Medical Co Ltd (002382) $10.54 Billion 10.97% 0.61x $763.05 Million
Andon Health Co Ltd (002432) $758.75 Million 1.34% 0.32x $2.12 Billion
Allmed Medical Products Co Ltd Class A (002950) $2.75 Billion 15.67% 0.82x $346.13 Million
Guangzhou Improve Med Instrument (300030) $592.55 Million 4.90% 0.10x $234.74 Million
Shanghai Tofflon Science Tech (300171) $2.41 Billion 11.06% 0.57x $784.88 Million
Truking Technology Ltd (300358) $320.32 Million 29.77% 1.35x $545.42 Million
Jiangxi Sanxin Medtec Co Ltd (300453) $1.41 Billion 16.14% 0.58x $438.45 Million
Shenyang Xingqi Pharmaceutical Co Ltd (300573) $1.55 Billion 13.64% 0.15x $1.62 Billion
Autek China Inc (300595) $105.24 Million 28.59% 0.10x $1.21 Billion